HHS Announces Walgreens' BARDA Award for COVID-19 Decentralized Clinical Study Under Project NextGen

Jul 23, 2024, 01:01 PM

Walgreens has received the BARDA Project NextGen Award to conduct a novel COVID-19 decentralized clinical study. The study, which is part of a Phase IV trial, will be carried out in partnership with the RRPV Consortium and will focus on a US FDA authorized or approved COVID-19 vaccine. The trial aims to identify correlates of protection for COVID vaccines and will take place at approximately 20 Walgreens sites, ranging from urban to rural locations. HHS announces the pharmacy-based clinical trial under Project NextGen.